Cargando…

Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review

Background and Objective: Excision repair cross complementing (ERCC) group genes play important roles in the nucleotide excision repair (NER) way, which can effectively remove bulky lesions and reduce UV-caused DNA damage by environmental chemicals. Polymorphisms in ERCCs were thought to be related...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yi, Hu, Yonghui, Zhang, Meng, Jiang, Runze, Liang, Chaozhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096373/
https://www.ncbi.nlm.nih.gov/pubmed/30123346
http://dx.doi.org/10.7150/jca.25356
_version_ 1783348091825422336
author Liu, Yi
Hu, Yonghui
Zhang, Meng
Jiang, Runze
Liang, Chaozhao
author_facet Liu, Yi
Hu, Yonghui
Zhang, Meng
Jiang, Runze
Liang, Chaozhao
author_sort Liu, Yi
collection PubMed
description Background and Objective: Excision repair cross complementing (ERCC) group genes play important roles in the nucleotide excision repair (NER) way, which can effectively remove bulky lesions and reduce UV-caused DNA damage by environmental chemicals. Polymorphisms in ERCCs were thought to be related to prostate cancer (PCa) risk. However, it has been unclear whether this relationship is consistent. This study aimed to obtain the overall profile regarding the associations between ERCCs polymorphisms and PCa risk. Materials and Methods: We identified relevant studies by a systematic search of PubMed, Medline, Embase, Google Scholar databases, Web of Science and Wanfang databases up to April 8, 2018. Odds ratios (ORs) with 95% confidential intervals (95%CIs) were conducted to evaluate the associations. All the statistical analyses were conducted basing on STATA 12.0 software. Results: Finally, a total of 29 previous studies published in 17 publications were included for four polymorphisms in two DNA repair genes (ERCC2-rs1799793, ERCC2-rs238406, ERCC2-rs13181 and ERCC5-rs17655). Overall, we observed no significant connection between these four polymorphisms and PCa risk. However, after stratifying the studies by ethnicity, ERCC2-rs1799793 polymorphism was associated with an increased risk of PCa in Asian patients and the relationship was subsequently validated with the allelic model, the homozygous model and the recessive model when extracting the data of Asian patients for specific analyses (B vs. A: OR = 1.537, 95%CI: 1.240-1.906, P(A)< 0.001; BB vs. AA: OR = 2.089, 95%CI: 1.388-3.145, P(A)< 0.001 and BB vs. BA + AA: OR = 1.929, 95%CI: 1.313-2.835, P(A)= 0.020). Furthermore, subgroup analyses were also conducted by Hardy-Weinberg Equilibrium (HWE) and source of control, negative results were identified for ERCC2-rs238406, ERCC2-rs13181 and ERCC5-rs17655 polymorphisms (P(A)> 0.050). Conclusion: To sum up, our work demonstrated that ERCC2-rs1799793 polymorphism is positively associated with PCa risk in Asian population. Further larger-scale studies with subjects of the same ethnicity and biological characteristics are required to verify these findings.
format Online
Article
Text
id pubmed-6096373
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-60963732018-08-17 Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review Liu, Yi Hu, Yonghui Zhang, Meng Jiang, Runze Liang, Chaozhao J Cancer Research Paper Background and Objective: Excision repair cross complementing (ERCC) group genes play important roles in the nucleotide excision repair (NER) way, which can effectively remove bulky lesions and reduce UV-caused DNA damage by environmental chemicals. Polymorphisms in ERCCs were thought to be related to prostate cancer (PCa) risk. However, it has been unclear whether this relationship is consistent. This study aimed to obtain the overall profile regarding the associations between ERCCs polymorphisms and PCa risk. Materials and Methods: We identified relevant studies by a systematic search of PubMed, Medline, Embase, Google Scholar databases, Web of Science and Wanfang databases up to April 8, 2018. Odds ratios (ORs) with 95% confidential intervals (95%CIs) were conducted to evaluate the associations. All the statistical analyses were conducted basing on STATA 12.0 software. Results: Finally, a total of 29 previous studies published in 17 publications were included for four polymorphisms in two DNA repair genes (ERCC2-rs1799793, ERCC2-rs238406, ERCC2-rs13181 and ERCC5-rs17655). Overall, we observed no significant connection between these four polymorphisms and PCa risk. However, after stratifying the studies by ethnicity, ERCC2-rs1799793 polymorphism was associated with an increased risk of PCa in Asian patients and the relationship was subsequently validated with the allelic model, the homozygous model and the recessive model when extracting the data of Asian patients for specific analyses (B vs. A: OR = 1.537, 95%CI: 1.240-1.906, P(A)< 0.001; BB vs. AA: OR = 2.089, 95%CI: 1.388-3.145, P(A)< 0.001 and BB vs. BA + AA: OR = 1.929, 95%CI: 1.313-2.835, P(A)= 0.020). Furthermore, subgroup analyses were also conducted by Hardy-Weinberg Equilibrium (HWE) and source of control, negative results were identified for ERCC2-rs238406, ERCC2-rs13181 and ERCC5-rs17655 polymorphisms (P(A)> 0.050). Conclusion: To sum up, our work demonstrated that ERCC2-rs1799793 polymorphism is positively associated with PCa risk in Asian population. Further larger-scale studies with subjects of the same ethnicity and biological characteristics are required to verify these findings. Ivyspring International Publisher 2018-07-16 /pmc/articles/PMC6096373/ /pubmed/30123346 http://dx.doi.org/10.7150/jca.25356 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Liu, Yi
Hu, Yonghui
Zhang, Meng
Jiang, Runze
Liang, Chaozhao
Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
title Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
title_full Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
title_fullStr Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
title_full_unstemmed Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
title_short Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
title_sort polymorphisms in ercc2 and ercc5 and risk of prostate cancer: a meta-analysis and systematic review
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096373/
https://www.ncbi.nlm.nih.gov/pubmed/30123346
http://dx.doi.org/10.7150/jca.25356
work_keys_str_mv AT liuyi polymorphismsinercc2andercc5andriskofprostatecancerametaanalysisandsystematicreview
AT huyonghui polymorphismsinercc2andercc5andriskofprostatecancerametaanalysisandsystematicreview
AT zhangmeng polymorphismsinercc2andercc5andriskofprostatecancerametaanalysisandsystematicreview
AT jiangrunze polymorphismsinercc2andercc5andriskofprostatecancerametaanalysisandsystematicreview
AT liangchaozhao polymorphismsinercc2andercc5andriskofprostatecancerametaanalysisandsystematicreview